0001209191-13-031938.txt : 20130612
0001209191-13-031938.hdr.sgml : 20130612
20130612192730
ACCESSION NUMBER: 0001209191-13-031938
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130612
FILED AS OF DATE: 20130612
DATE AS OF CHANGE: 20130612
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Trius Therapeutics Inc
CENTRAL INDEX KEY: 0001356857
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 201320630
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6310 NANCY RIDGE DR SUITE 105
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-452-0370
MAIL ADDRESS:
STREET 1: 6310 NANCY RIDGE DR SUITE 105
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Finn John
CENTRAL INDEX KEY: 0001479788
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34828
FILM NUMBER: 13909883
MAIL ADDRESS:
STREET 1: 6310 NANCY RIDGE DRIVE, SUITE 101
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2013-06-12
0
0001356857
Trius Therapeutics Inc
TSRX
0001479788
Finn John
C/O TRIUS THERAPEUTICS, INC.
6310 NANCY RIDGE DR, # 105
SAN DIEGO
CA
92121
0
1
0
0
Chief Scientific Officer
Common Stock
2013-06-12
4
S
0
3000
9.0833
D
177860
I
By the John and Debbie Finn Trust
Common Stock
2151
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 21, 2012
The weighted average sales price for the transaction reported was $9.0833, and the range of prices were between $9.05 and $9.20. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided
/s/ Michael Morneau, Attorney-in-Fact
2013-06-12